SCHEMBL2531922

SCHEMBL2531922

O=CC1=C(Cl)CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL342405 0.94
SCHEMBL31277248 0.92 ALDH1A1 (0.30)
SCHEMBL2945963 0.92 ALDH1A1 (0.30)
SCHEMBL14641322 0.92 ALDH1A1 (0.30)
SCHEMBL2945960 0.92 ALDH1A1 (0.30)
SCHEMBL16505672 0.92 ALDH1A1 (0.30)
SCHEMBL15285099 0.92 ALDH1A1 (0.30)
SCHEMBL30895203 0.92 ALDH1A1 (0.30)
SCHEMBL4021119 0.78
SCHEMBL4027953 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-6228094-A None JP disclosed
CN-120004902-A Heteroaryl heterocycles and uses thereof 和记黄埔医药(上海)有限公司 2025-05-16 CN disclosed
CN-119925375-A Heteroaryl heterocycles and uses thereof 和记黄埔医药(上海)有限公司 2025-05-06 CN disclosed
CN-119930630-A Heteroaryl heterocycles and uses thereof 和记黄埔医药(上海)有限公司 2025-05-06 CN disclosed
CN-115151535-B Heteroaryl heterocycles and uses thereof 和记黄埔医药(上海)有限公司 2025-01-10 CN disclosed
WO-2024109688-A1 PYRROLE FUSED RING DERIVATIVE AND PHARMACEUTICAL USE THEREOF 成都百裕制药股份有限公司 2024-05-30 WO disclosed
CN-114478424-B Preparation method of azlactone derivative with cycloalkenyl substituted at beta position 浙江工业大学 2023-09-26 CN disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-11478474-B2 2-(3′-(hydroxymethyl)-1-methyl-5-((5-(2-methyl-4-(oxetan-3-yl)piperazin-1-yl)pyridin-2-yl)amino)-6-oxo-1,6-dihydro-[3,4′-bipyridin]-2′-yl)-7,7-dimethyl-7,8-dihydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one as a BTK inhibitor HUTCHISON MEDIPHARMA LIMITED (CN) 2022-10-25 US disclosed
CN-115151535-A Heteroaryl heterocyclic compounds and uses thereof 和记黄埔医药(上海)有限公司 2022-10-04 CN disclosed
US-20090170911-A1 NOVEL AZOLE COMPOUND AJINOMOTO CO. INC (JP) 2009-07-02 US disclosed
US-7517996-B2 Azole compound AJINOMOTO CO., INC. (JP) 2009-04-14 US disclosed
US-20060194850-A1 Novel azole compound AJINOMOTO CO. INC (JP) 2006-08-31 US disclosed
WO-2005049568-A1 A PROCESS FOR INDUSTRIALLY VIABLE PREPARATION OF (S,S,S) PHENYLMETHYL-2-AZABICYCLO-[3.3.0]-OCTANE-3-CARBOXYLATE TOSYLATE BABU POTLURI RAMESH (IN) 2005-06-02 WO disclosed
US-5550255-A Cis, endo-2-azabicycloalkane-3-carboxylic acid derivatives HOECHST AKTIENGESELLSCHAFT (DE) 1996-08-27 US disclosed
JP-H06228094-A CIS, ENDO-2-AZABICYCLOALKANE-3-CARBOXYLIC ACID DERIVATIVE AND ITS PREPARATION HOECHST AG 1994-08-16 JP disclosed
EP-0173199-B1 Cis, endo-2-azabicycloalkane-3-carboxylic-acid derivatives, processes for their manufacture, their use and intermediate products obtained in their manufacture HOECHST AG (DE) 1994-07-13 EP disclosed
US-4886827-A Cis,endo-2-azabicycloalkane-3-carboxylic acid derivatives, their use and intermediates in their preparation HOECHST AKTIENGESELLSCHAFT (DE) 1989-12-12 US disclosed
EP-0174071-A2 Dihydropyridine derivatives and their production, formulation and use as pharmaceuticals FISONS plc (GB) 1986-03-12 EP disclosed
EP-0173199-A1 Cis, endo-2-azabicycloalkane-3-carboxylic-acid derivatives, processes for their manufacture, their use and intermediate products obtained in their manufacture HOECHST AKTIENGESELLSCHAFT (DE) 1986-03-05 EP disclosed